Emerging BRAF inhibitors for melanoma

By Sabbatino Francesco   Wang Yangyang   Wang Xinhui   Ferrone Soldano   Ferrone Cristina R  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 4, 2013-12 ,pp. : 431-443

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in the Research and Development of B-Raf Inhibitors

By  

Current Medicinal Chemistry, Vol. 17, Iss. 16, 2010-06 ,pp. : 1618-1634

Bentham Science Publishers

Access to resources Recommend Favorite

The nature and management of metastatic melanoma after progression on BRAF inhibitors: Effects of extended BRAF inhibition

By Chan Matthew M. K.   Haydu Lauren E.   Menzies Alexander M.   Azer Mary W. F.   Klein Oliver   Lyle Megan   Clements Arthur   Guminski Alexander   Kefford Richard F.   Long Georgina V.  

Cancer, Vol. 120, Iss. 20, 2014-10 ,pp. : 3142-3153

Blackwell Publishing

Access to resources Recommend Favorite

Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors

By Ackerman Allison   Klein Oliver   McDermott David F.   Wang Wei   Ibrahim Nageatte   Lawrence Donald P.   Gunturi Anasuya   Flaherty Keith T.   Hodi F. Stephen   Kefford Richard   Menzies Alexander M.   Atkins Michael B.   Long Georgina V.   Sullivan Ryan J.  

Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. : 1695-1701

Blackwell Publishing

Access to resources Recommend Favorite

Targeted Therapy for Brain Tumours: Role of PARP Inhibitors

By  

Current Cancer Drug Targets, Vol. 12, Iss. 3, 2012-03 ,pp. : 218-236

Bentham Science Publishers

Access to resources Recommend Favorite